CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has promoted Akshay Vaishnaw, M.D., Ph.D., to the role of Senior Vice President, Clinical Research. In this role, Dr. Vaishnaw will be responsible for continued leadership of the company’s clinical activities; he will continue to report to John Maraganore, Alnylam’s Chief Executive Officer.
